Literature DB >> 29684925

Minimally Invasive Resection of Deep-seated High-grade Gliomas Using Tubular Retractors and Exoscopic Visualization.

Rajiv Iyer1, Kaisorn L Chaichana2.   

Abstract

BACKGROUND AND STUDY AIMS/
OBJECTIVE: Deep-seated high-grade gliomas (HGGs) represent a unique surgical challenge because they reside deep to critical cortical and subcortical structures and infiltrate functional areas of the brain. Therefore, accessing and resecting these tumors can often be challenging and associated with significant morbidity. We describe the use of minimally invasive approaches to access deep-seated HGGs to achieve extensive resections while minimizing surgical morbidity.
MATERIALS AND METHODS: All patients who underwent resection of a deep-seated intraparenchymal HGG with the use of a tubular retractor with exoscopic visualization from January 2016 to May 2017 were identified prospectively at a single institution. Variables evaluated included tumor location, pre- and postoperative neurologic function, extent of resection, and length of hospital stay.
RESULTS: Overall, 14 patients underwent resection of an HGG (11 glioblastomas, 3 anaplastic astrocytomas) with a tubular retractor under exoscopic visualization. Seven tumors (50%) involved the thalamus, three (21%) the motor corticospinal tract, two (14%) the inferior frontal occipital fasciculus, one (7%) each the basal ganglia and optic pathway. The median preoperative Karnofsky Performance Score (KPS) was 70 (interquartile range: 55-80), where the major presenting symptom was motor weakness in seven (50%). The average plus or minus the standard error of the mean percentage resection was 97.0 ± 1.2%. The median hospital stay was 4 days (range: 2-7). At 1 month postoperatively, median postoperative KPS (within 30 days) was 87 (range: 77-90), where eight (57%) were improved, five (36%) were stable, and one (7%) was worse postoperatively.
CONCLUSIONS: Deep-seated HGGs can be accessed, visualized, and resected using tubular retractors and exoscopic visualization with minimal morbidity. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29684925     DOI: 10.1055/s-0038-1641738

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  9 in total

1.  In Reply: Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.

Authors:  Yoshua Esquenazi; Nelson Moss; Viviane Tabar
Journal:  Neurosurgery       Date:  2019-05-01       Impact factor: 4.654

Review 2.  Beyond magnification and illumination: preliminary clinical experience with the 4K 3D ORBEYE™ exoscope and a literature review.

Authors:  Michael Amoo; Jack Henry; Mohsen Javadpour
Journal:  Acta Neurochir (Wien)       Date:  2021-04-02       Impact factor: 2.216

3.  LITTing up Gliomas-Is the Future Bright?

Authors:  Philip J O'Halloran; Jack Henry; Michael Amoo; Aristotelis Kalyvas; Nilesh Mohan; Gelareh Zadeh; Suneil K Kalia; Paul N Kongkham
Journal:  World Neurosurg X       Date:  2022-09-09

Review 4.  Surgical Neuro-Oncology: Management of Glioma.

Authors:  Dana Mitchell; Jack M Shireman; Mahua Dey
Journal:  Neurol Clin       Date:  2022-03-31       Impact factor: 3.787

Review 5.  Contemporary Surgical Management of Deep-Seated Metastatic Brain Tumors Using Minimally Invasive Approaches.

Authors:  Lina Marenco-Hillembrand; Keila Alvarado-Estrada; Kaisorn L Chaichana
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

6.  Combined transoral exoscope and OArm-assisted approach for craniovertebral junction surgery: Light and shadows in single-center experience with improving technologies.

Authors:  Massimiliano Visocchi; Pier Paolo Mattogno; Pasqualino Ciappetta; Giuseppe Barbagallo; Francesco Signorelli
Journal:  J Craniovertebr Junction Spine       Date:  2020-11-26

Review 7.  The Exoscope in Neurosurgery: An Overview of the Current Literature of Intraoperative Use in Brain and Spine Surgery.

Authors:  Nicola Montemurro; Alba Scerrati; Luca Ricciardi; Gianluca Trevisi
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

8.  Risk Factors for Early Hydrocephalus on Post Unilateral Thalamic Tumor Resection.

Authors:  Linpeng Zhang; Chen Wang; Xianwei Zeng
Journal:  Front Surg       Date:  2022-04-08

9.  Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: Potential role in clinical decision making.

Authors:  Jun Chen; Toral R Patel; Marco C Pinho; Changho Choi; Crystal E Harrison; Jeannie D Baxter; Kelley Derner; Salvador Pena; Jeff Liticker; Jaffar Raza; Ronald G Hall; Galen D Reed; Chunyu Cai; Kimmo J Hatanpaa; James A Bankson; Robert M Bachoo; Craig R Malloy; Bruce E Mickey; Jae Mo Park
Journal:  Neurooncol Adv       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.